Float Short %

5.14

Margin Of Safety %

-22

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.11

EPS Last/This Y

11.93

EPS This/Next Y

0.41

Price

94.66

Target Price

112.1

Analyst Recom

2.42

Performance Q

23.72

Relative Volume

2.08

Beta

1.38

Ticker: ILMN

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-07	ILMN	97.33	0.22	1.47	78557
2025-07-08	ILMN	99.27	0.23	1.94	79744
2025-07-09	ILMN	97.49	0.24	0.76	80242
2025-07-10	ILMN	100.1	0.24	0.71	80241
2025-07-11	ILMN	99.26	0.25	1.67	81203
2025-07-14	ILMN	98.71	0.24	0.75	79566
2025-07-15	ILMN	97.17	0.24	0.70	79949
2025-07-16	ILMN	96.96	0.24	0.61	80140
2025-07-17	ILMN	97.93	0.26	0.20	80300
2025-07-18	ILMN	96.19	0.25	0.87	81197
2025-07-21	ILMN	95.03	0.40	0.02	52188
2025-07-22	ILMN	102.05	0.26	0.19	73240
2025-07-23	ILMN	104.61	0.25	0.31	74681
2025-07-24	ILMN	107.6	0.26	0.86	75214
2025-07-25	ILMN	109.33	0.27	0.17	76695
2025-07-28	ILMN	109.9	0.26	1.87	74818
2025-07-29	ILMN	108.69	0.26	1.06	75263
2025-07-30	ILMN	106.72	0.27	1.29	75710
2025-07-31	ILMN	102.73	0.27	0.17	76188
2025-08-01	ILMN	94.65	0.26	0.57	92327
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-07	ILMN	97.12	181.3	1668.0	4.23
2025-07-08	ILMN	99.27	181.3	1717.2	4.23
2025-07-09	ILMN	97.44	181.3	1683.3	4.23
2025-07-10	ILMN	100.05	181.3	1721.4	4.23
2025-07-11	ILMN	99.25	181.3	1714.5	4.23
2025-07-14	ILMN	98.53	181.3	1692.8	4.23
2025-07-15	ILMN	97.15	181.3	1687.1	4.23
2025-07-16	ILMN	96.97	181.3	1697.3	4.23
2025-07-17	ILMN	97.93	181.3	1707.3	4.23
2025-07-18	ILMN	96.15	181.3	1683.5	4.23
2025-07-21	ILMN	94.78	181.3	1686.9	4.23
2025-07-22	ILMN	102.03	181.3	1763.1	4.23
2025-07-23	ILMN	104.61	181.3	1720.3	4.23
2025-07-24	ILMN	107.64	180.9	1723.4	4.24
2025-07-25	ILMN	109.30	180.9	1712.0	4.24
2025-07-28	ILMN	109.90	180.9	1703.6	4.24
2025-07-29	ILMN	108.71	180.9	1689.8	4.24
2025-07-30	ILMN	106.66	180.9	1682.8	4.24
2025-07-31	ILMN	102.71	180.9	1667.4	4.24
2025-08-01	ILMN	94.66	180.9	1632.5	4.24
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-07	ILMN	0.40	1.27	4.10
2025-07-08	ILMN	0.40	1.27	4.10
2025-07-09	ILMN	0.40	1.27	4.10
2025-07-10	ILMN	0.40	1.27	4.10
2025-07-11	ILMN	0.40	1.27	4.55
2025-07-14	ILMN	0.40	1.50	4.55
2025-07-15	ILMN	0.40	1.50	4.55
2025-07-16	ILMN	0.40	1.50	4.55
2025-07-17	ILMN	0.40	1.50	4.55
2025-07-18	ILMN	0.40	1.50	4.55
2025-07-21	ILMN	0.40	1.12	4.55
2025-07-22	ILMN	0.40	1.12	4.55
2025-07-23	ILMN	0.40	1.12	4.55
2025-07-24	ILMN	0.40	1.12	4.55
2025-07-25	ILMN	0.40	1.12	5.14
2025-07-28	ILMN	0.40	0.93	5.14
2025-07-29	ILMN	0.40	0.93	5.14
2025-07-30	ILMN	0.40	0.93	5.14
2025-07-31	ILMN	0.40	0.93	5.14
2025-08-01	ILMN	0.40	0.93	5.14
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

1.01

Avg. EPS Est. Next Quarter

1.08

Insider Transactions

0.4

Institutional Transactions

0.93

Beta

1.38

Average Sales Estimate Current Quarter

1048

Average Sales Estimate Next Quarter

1055

Fair Value

73.96

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

82.5

Max Drawdown 5-Year %

-86.2

Target Price

112.1

P/E

11.99

Forward P/E

19.74

PEG

1.23

P/S

3.5

P/B

6.36

P/Free Cash Flow

17.11

EPS

7.9

Average EPS Est. Cur. Y

4.24

EPS Next Y. (Est.)

4.65

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.37

Relative Volume

2.08

Return on Equity vs Sector %

-64.5

Return on Equity vs Industry %

-51.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

1632.5

Illumina, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 8970

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

stock quote shares ILMN – Illumina, Inc. Stock Price stock today

news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ILMN – Illumina, Inc. yahoo finance google finance

stock history ILMN – Illumina, Inc. invest stock market

stock prices ILMN premarket after hours

ticker ILMN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ILMN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y